Biotech News

Aspyron Inc. announces a Tier II qualified offering under SEC Regulation A+ of up to 2,500,000 shares of common stock at a price of $.40 per share raising up to $1,000,000
SUMMIT COUNTY, Colo. - Feb. 7, 2018 - -- Keystone Symposia is pleased to announce that it will host a free ePanel discussion on the topic of "Tech Transfer for Medical Advances: Challenges and Opportunities Commercializing Academic Biomedical Research"...
Rubix LS creating footprints in more areas….now in Washington DC
CAMBRIDGE, England - Dec. 14, 2017 - -- Biosceptre has received over £8M into its' series A raise which will be used to resource the next stage of the companies' development; progression into the clinic of Biosceptre's first systemic products against...
Join the Boston Biotech Meetup for Advances in Gene Therapy, an evening of networking, presentations and discussion with local scientists.
BERKELEY, Calif. - March 27, 2017 - -- Leadership, employees and stakeholders of Berkeley Lights celebrate the launch of a new brand-focused website which tells their story: the partnership of science and engineering, to transform the lives of...
IRVINE, Calif. - March 27, 2017 - -- The staggering cost of cancer treatment means only patients living in the wealthiest countries have access to the latest treatment options against cancer. Even among the most affluent countries like the US, many...
Biosceptre has published a clinical study demonstrating that its topical drug BIL010t provides a novel, safe and tolerable topical therapy for BCC in the British Journal of Dermatology (BJD)
IRVINE, Calif. - Feb. 15, 2017 - -- HOPE BIOSCIENCES, INC. announced today that Dr. Michael Adam has joined the management team to oversee Pharmaceutical and Manufacturing Operations as well as Regulatory Affairs and Quality Assurance.
SARASOTA, Fla. - Nov. 10, 2016 - -- Generis Knowledge Management Inc. announced today that a top 10 global biotechnology company has chosen CARA to replace their existing Vault system for the distribution of PSURs, EdTs and associated documents to...
Eight Student Innovators Will Present November 11, 2016 at Ocean Exchange in Savannah, GA in Georgia Southern University College of Business Sponsored Competition.
tealbook's potential for market traction and revenue growth recognized by UNPACK Boston's team of potential partners, customers and investors.
New animal facilities for rodent pharmacokinetic studies launched
Dr. Daniel Holterman is now Chief Science Officer and CLIA Lab Director at Beacon Biomedical
Biosceptre announces today that Professor Francesco Di Virgilio, an international expert on the role of P2X7 in cancer, has joined the Scientific Advisory Board alongside its existing members, Sir Gregory Winter and Professor Terence Rabbitts.
Beacon has reached some significant milestones with its BeScreened™-CRC colorectal cancer screening test having demonstrated in its initial clinical data 95% accuracy across all patient demographics. Prior to and following the meeting, management...
Singular Research Hosts SPRING SELECT "Best of the Uncovered" Investment Conference
The MedtoMarket founders are excited to announce the addition of industry veteran, Ms. Loxley A. Browne, as Senior Vice President of Communications.
AUSTIN, Texas - May 18, 2016 - -- Mystic Pharmaceuticals, Inc., a privately held, life science technology company, announced today it has received a patent from the Japanese Patent Office for its "Combination Unit Dose Dispensing Container" (Japanese...
Beacon Biomedical Inc. Appoints Industry Veteran To Lead Cancer Screening Technology Commercialization
Beacon Biomedical Inc. Appoints Industry Veteran To Lead Cancer Screening Technology Commercialization